IRIS
SCHWARTZ, PETER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.816
AS - Asia 15.713
EU - Europa 12.166
SA - Sud America 1.974
AF - Africa 435
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 20
Totale 49.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.449
CN - Cina 8.533
SG - Singapore 3.314
IE - Irlanda 2.596
UA - Ucraina 2.031
DE - Germania 1.820
HK - Hong Kong 1.539
BR - Brasile 1.471
FI - Finlandia 1.188
RU - Federazione Russa 1.111
VN - Vietnam 1.069
SE - Svezia 901
IT - Italia 832
FR - Francia 748
GB - Regno Unito 577
IN - India 268
CA - Canada 215
ZA - Sudafrica 177
BD - Bangladesh 171
AR - Argentina 169
IQ - Iraq 149
JP - Giappone 97
MX - Messico 95
EC - Ecuador 77
PK - Pakistan 72
CO - Colombia 71
TR - Turchia 69
VE - Venezuela 69
NL - Olanda 68
MA - Marocco 61
ID - Indonesia 53
AT - Austria 49
ES - Italia 48
BE - Belgio 47
PH - Filippine 47
PL - Polonia 41
UZ - Uzbekistan 40
CL - Cile 38
SA - Arabia Saudita 36
KE - Kenya 35
PY - Paraguay 33
TN - Tunisia 33
MU - Mauritius 32
MY - Malesia 31
AU - Australia 29
JO - Giordania 29
EG - Egitto 26
AE - Emirati Arabi Uniti 24
IR - Iran 22
AZ - Azerbaigian 21
PE - Perù 19
NP - Nepal 18
EU - Europa 17
IL - Israele 17
DZ - Algeria 16
NZ - Nuova Zelanda 16
BO - Bolivia 15
ET - Etiopia 15
CR - Costa Rica 14
OM - Oman 13
UY - Uruguay 12
AL - Albania 11
KZ - Kazakistan 11
NI - Nicaragua 10
CZ - Repubblica Ceca 9
LV - Lettonia 9
RO - Romania 9
SN - Senegal 9
BG - Bulgaria 8
LB - Libano 8
LT - Lituania 8
PS - Palestinian Territory 8
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
PT - Portogallo 7
RS - Serbia 7
CH - Svizzera 6
KG - Kirghizistan 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
GE - Georgia 5
JM - Giamaica 5
KR - Corea 5
KW - Kuwait 5
QA - Qatar 5
TT - Trinidad e Tobago 5
HN - Honduras 4
AM - Armenia 3
BH - Bahrain 3
BW - Botswana 3
CG - Congo 3
GR - Grecia 3
HR - Croazia 3
MD - Moldavia 3
SY - Repubblica araba siriana 3
ZW - Zimbabwe 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
Totale 49.118
Salva come PNG Salva come JPEG
Città #
Chandler 2.637
Dublin 2.591
Jacksonville 2.589
Nanjing 2.096
Singapore 1.555
Hong Kong 1.504
Dallas 1.481
Ashburn 1.473
San Jose 1.446
Beijing 964
Boardman 902
Nanchang 851
Princeton 639
Lawrence 602
Shenyang 600
Changsha 575
Hebei 571
Wilmington 559
Lauterbourg 540
Jiaxing 511
Munich 482
Helsinki 424
Medford 408
Los Angeles 390
Ho Chi Minh City 375
Tianjin 331
Hangzhou 322
Hanoi 259
Moscow 232
Redondo Beach 223
Buffalo 208
Ann Arbor 195
Milan 154
New York 151
Woodbridge 148
Johannesburg 138
São Paulo 137
Shanghai 132
Verona 116
Norwalk 111
Tokyo 92
Toronto 79
Frankfurt am Main 71
Nuremberg 70
Houston 69
Orem 67
Santa Clara 66
Baghdad 64
Seattle 64
Fairfield 61
Kunming 59
Des Moines 57
Pavia 53
Zhengzhou 53
Guangzhou 52
Mcallen 52
Brooklyn 51
Chennai 50
Washington 47
Chicago 44
Da Nang 44
Falkenstein 44
Jinan 44
Falls Church 42
San Francisco 41
Haiphong 38
Montréal 37
Brussels 36
London 36
Ningbo 36
Tashkent 36
Warsaw 36
Montreal 34
Belo Horizonte 33
Nairobi 33
Rio de Janeiro 33
Brasília 32
Rome 32
Stockholm 32
Turku 32
Boston 31
Curitiba 29
Guayaquil 29
The Dalles 29
Caracas 28
Denver 28
Amman 27
Atlanta 27
Manchester 27
Mexico City 27
Dhaka 26
Phoenix 25
Amsterdam 24
Biên Hòa 24
Fuzhou 24
Lahore 24
Dearborn 23
Pune 22
Secaucus 21
Vienna 21
Totale 32.090
Salva come PNG Salva come JPEG
Nome #
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 298
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 267
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. 265
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. 257
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 249
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 245
Calcio antagonisti e aritmie da riperfusione miocardica 204
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 163
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 152
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 149
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 148
[Infant mortality and sudden crib death in Lombardy]. 146
Long QT and short QT syndromes. 146
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 145
[Neonatal electrocardiography and the sudden infant death syndrome (SIDS)]. 144
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 142
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 142
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 135
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 135
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 135
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 133
FGF12 is a candidate Brugada syndrome locus. 132
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 131
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 130
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 127
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. 126
Alpha 1-adrenergic blockade and sudden cardiac death. 126
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 126
Effect of Considering the Relatives' Quality of Life in Cost-Utility Studies 126
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 125
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 124
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 123
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 122
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 122
Long QT syndrome-associated mutations in intrauterine fetal death. 121
[Cardio-cardiac sympathico-vagal reflex]. 120
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 119
[Sympathetic reflex induced by experimental coronary occlusion]. 118
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. 118
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 116
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 116
Risk stratification in the Long-QT Syndrome 115
QT prolongation and sudden infant death syndrome - from theory to evidence. 115
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 113
Inherited cardiac arrhythmia syndrome. Role of potassium channels 113
An experimental approach to the choice of antiarrhythmic therapy. 113
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 112
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 112
A Recessive Variant of the Romano-Ward Long QT Syndrome 111
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 111
[Neural mechanisms of sudden death]. 111
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 111
The genetics underlying acquired long QT syndrome: impact for genetic screening. 111
All LQT3 patients need an ICD. True or false? 110
Cardiac sodium channel dysfunction in sudden infant death syndrome. 110
Adrenergic Arrhythmogenesis and The Long QT syndrome 110
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 110
Unexplained cardiac arrest. The need for a prospective registry. 110
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 110
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 110
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 109
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 109
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 109
Cardiac potassium channel dysfunction in sudden infant death syndrome. 109
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 109
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 109
QT lungo, sindrome del 108
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 108
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 108
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 108
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 107
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 107
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 107
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 107
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 107
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 107
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 106
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 106
Mortalità infantile e morte improvvisa in culla in Lombardia 106
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 105
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 105
A molecular basis for the therapy of the long QT syndrome 104
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 104
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 104
The long QT syndrome. Prospective longitudinal study of 328 families. 103
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 103
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 103
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes 102
[Long-QT caused by drugs and torsade de pointes: a genetic basis?]. 102
Prevalence of the congenital long-QT syndrome. 102
Autonomic nervous system and arrhythmias. 102
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 102
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 101
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 101
The ICD for the long QT syndrome: which indications, complications, and results? 100
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 100
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 100
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 100
New mutations in the KVLQT1 potassium channel that cause long QT Syndrome. 99
Can a message from the dead save lives? 99
Totale 12.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.172 0 0 0 0 0 0 0 0 0 560 503 109
2021/20222.399 31 10 72 28 34 176 30 129 173 67 389 1.260
2022/20237.622 920 454 57 608 834 887 6 453 3.095 34 170 104
2023/20242.413 258 528 107 197 280 646 52 128 7 67 69 74
2024/20257.210 120 682 193 251 110 284 616 755 1.596 222 625 1.756
2025/202614.248 1.110 1.195 2.182 1.435 1.625 756 3.139 637 1.276 893 0 0
Totale 49.454